NMS · Medical - Devices

VREX (VREX) Stock

$11.06 -0.63% NMS: VREX Healthcare

Valuation

MetricValue
Price$11.06
Market Cap$465.63M
P/E Ratio-5.48
P/B Ratio0.83
P/S Ratio0.48
EPS (TTM)$-1.70
52-Week High$14.56
52-Week Low$6.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.80%
ROA-6.32%
ROCE-5.76%
Gross Margin-3.20%
Operating Margin-3.31%
Net Margin-9.64%
Debt/Equity0.80
Current Ratio3.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$818.0M$859.0M$893.0M$811.0M$845.0M
Operating Profit$74.0M$88.0M$77.0M$32.0M$-28.0M
Net Profit$17.0M$30.0M$47.0M$-48.0M$-70.0M
EPS$0.43$0.73$0.96$-1.17$-1.70
Op Margin9.1%10.3%8.6%4.0%-3.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.1B$1.2B$1.3B$1.2B$1.1B
Total Liabilities$651.0M$638.0M$669.0M$668.0M$621.0M
Cash$145.0M$89.0M$153.0M$169.0M$145.0M
Borrowings$459.0M$436.0M$470.0M$470.0M$402.0M

Latest News

Are Investors Undervaluing VAREX IMAGING (VREX) Right Now? Zacks · Jul 13, 2026 Should Value Investors Buy Phibro Animal Health (PAHC) Stock? Zacks · Jul 6, 2026 Wall Street Analysts Think VAREX IMAGING (VREX) Could Surge 61.6%: Read This Before Placing a Bet Zacks · Jun 24, 2026 Is VAREX IMAGING (VREX) Stock Undervalued Right Now? Zacks · Jun 19, 2026 Wall Street Analysts See a 78.39% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High? Zacks · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$93.0M$17.0M$108.0M$47.0M$42.0M
Investing Cash Flow$-31.0M$-70.0M$-66.0M$-54.0M$-13.0M
Financing Cash Flow$-1.0M$6.0M$2.0M$-2.0M$-4.0M
Net Cash Flow$44.0M$-55.0M$63.0M$16.0M$-23.0M
Free Cash Flow$78.0M$-4.0M$88.0M$20.0M$19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-7.54%
Quick Ratio1.43
Interest Coverage-0.78
Return 1Y39.40%
Return 3Y-53.69%
Return 5Y-58.40%

Ownership

Insiders Held1.66%
Institutions Held100.21%
Institutions Float Held101.91%
Institutional HolderSharesReport Date
Pzena Investment Management LLC3,992,2802026-03-31
Blackrock Inc.3,817,8302026-03-31
Allspring Global Investments Holdings, LLC2,647,2632026-03-31
Neuberger Berman Group, LLC1,924,9492026-03-31
Vanguard Capital Management LLC1,820,3362026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
CBLL $18.81 +3.07% -11.62 $713.70M 0.00%
CGEM $17.21 -1.49% -3.76 $1.06B 0.00%
CTKB $4.38 -1.79% -7.25 $565.64M 0.00%

About VREX

VREX is led by CEO Sunny S. Sanyal, employs 2,300 people, headquartered in US, publicly traded since 2017.

VREX stock trades at $11.06 with a market capitalization of $465.63M. The stock is valued at a price-to-earnings (P/E) ratio of -5.48, price-to-book of 0.83, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $6.76 and $14.56, and currently trades 24.1% below its 52-week high.

On profitability, VREX generates a return on equity (ROE) of -14.80%, return on capital employed of -5.76%, an operating margin of -3.31%, a net profit margin of -9.64%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides